Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Germol is a brand of antiseptic and hygiene products developed and marketed by Shalina Laboratories, primarily targeting the African healthcare market. The flagship product, Germol Antiseptic Liquid, is a combination of chlorhexidine gluconate and cetrimide, serving as a generic equivalent to the well-known brand Savlon. Chlorhexidine is a biguanide antiseptic that provides broad-spectrum antimicrobial activity by disrupting microbial cell membranes and denaturing proteins. Cetrimide is a quaternary ammonium compound that acts as both a detergent and an antiseptic, enhancing the penetration and efficacy of the formulation against gram-positive and gram-negative bacteria. Germol is widely used for wound cleansing, skin disinfection, and general household hygiene to prevent infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine + cetrimide.